is a common depigmenting disorder with a worldwide prevalence of 0.5%-2%. 1 Narrowband-ultraviolet B (NB-UVB) phototherapy acts both in immunomodulation and stimulation of melanocyte activity. 2 Literature on vitamin D as an auxiliary treatment for vitiligo is limited. We evaluate the efficacy of Vitamin D3 supplementation with NB-UVB in vitiligo patients.After approval by our Institutional Ethics Review Board, we performed a randomized (1:1), triple-blind, placebocontrolled trial at the